Published in Semin Thorac Cardiovasc Surg on January 01, 2009
The golden age of minimally invasive cardiothoracic surgery: current and future perspectives. Future Cardiol (2011) 1.32
Integrating economic evaluation methods into clinical and translational science award consortium comparative effectiveness educational goals. Acad Med (2011) 1.30
A minimally invasive approach is more cost-effective than a traditional sternotomy approach for mitral valve surgery. J Thorac Cardiovasc Surg (2011) 1.11
Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med (2001) 18.91
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med (2009) 17.17
Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA (2003) 14.72
Is technological change in medicine worth it? Health Aff (Millwood) (2001) 5.97
Composite outcomes in randomized trials: greater precision but with greater uncertainty? JAMA (2003) 5.67
Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation (2007) 4.67
Health care and the American Recovery and Reinvestment Act. N Engl J Med (2009) 4.03
Economic foundations of cost-effectiveness analysis. J Health Econ (1997) 3.33
Problems with interval estimates of the incremental cost-effectiveness ratio. Med Decis Making (1999) 1.63
Tying clinical research to patient care by use of an observational database. Stat Med (1985) 1.56
Left ventricular assist devices as permanent heart failure therapy: the price of progress. Ann Surg (2003) 1.30
Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era. J Heart Lung Transplant (2006) 1.03
INvestigation of STEnt grafts in patients with type B Aortic Dissection: design of the INSTEAD trial--a prospective, multicenter, European randomized trial. Am Heart J (2005) 1.01
Decision analysis and economic modelling: a primer. Eur J Gastroenterol Hepatol (2004) 0.97
Patient selection for left ventricular assist device therapy. Ann Thorac Surg (2003) 0.92
Cost-of-illness analyses for policy making: a cautionary tale of use and misuse. Expert Rev Pharmacoecon Outcomes Res (2003) 0.89
Special report: cost-effectiveness of left-ventricular assist devices as destination therapy for end-stage heart failure. Technol Eval Cent Assess Program Exec Summ (2004) 0.86
Measurement of end points in heart failure trials: jousting at windmills? Mt Sinai J Med (2004) 0.78
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94
Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med (2014) 7.23
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 6.94
Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med (2013) 6.21
Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med (2015) 4.77
Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. J Vasc Surg (2010) 3.45
Blood transfusion and infection after cardiac surgery. Ann Thorac Surg (2013) 3.35
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. N Engl J Med (2015) 3.11
Progress versus precision: challenges in clinical trial design for left ventricular assist devices. Ann Thorac Surg (2006) 2.17
Effect of gender on long-term survival after abdominal aortic aneurysm repair based on results from the Medicare national database. J Vasc Surg (2011) 1.81
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 1.80
The cost of medical management in advanced heart failure during the final two years of life. J Card Fail (2008) 1.71
Despite decreased wait-list times for lung transplantation, lung allocation scores continue to increase. Chest (2008) 1.64
Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: an analysis of the United Network of Organ Sharing database. Circulation (2006) 1.62
National trend in prevalence, cost, and discharge disposition after subdural hematoma from 1998-2007. Crit Care Med (2011) 1.53
Laser energy source in surgical atrial fibrillation ablation: preclinical experience. Ann Thorac Surg (2006) 1.47
Long-term outcomes with a minimally invasive approach for resection of cardiac masses. Ann Thorac Surg (2010) 1.45
Kyphoplasty and vertebroplasty: trends in use in ambulatory and inpatient settings. Spine J (2011) 1.41
Sequential Organ Failure Assessment Score at Presentation Predicts Survival in Patients Treated With Percutaneous Veno-Arterial Extracorporeal Membrane Oxygenation. J Invasive Cardiol (2016) 1.38
Efficient estimation of log-normal means with application to pharmacokinetic data. Stat Med (2006) 1.34
The golden age of minimally invasive cardiothoracic surgery: current and future perspectives. Future Cardiol (2011) 1.32
Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH trial. Ann Thorac Surg (2004) 1.31
Integrating economic evaluation methods into clinical and translational science award consortium comparative effectiveness educational goals. Acad Med (2011) 1.30
Left ventricular assist devices as permanent heart failure therapy: the price of progress. Ann Surg (2003) 1.30
Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. J Heart Lung Transplant (2010) 1.28
Minimally invasive versus sternotomy approach for mitral valve surgery: a propensity analysis. Ann Thorac Surg (2010) 1.23
Alternate waiting list strategies for heart transplantation maximize donor organ utilization. Ann Thorac Surg (2005) 1.22
High lung allocation score is associated with increased morbidity and mortality following transplantation. Chest (2009) 1.22
The ARUBA trial: current status, future hopes. Stroke (2010) 1.22
Optimal surgical management of severe ischemic mitral regurgitation: to repair or to replace? J Thorac Cardiovasc Surg (2011) 1.17
Association of device surface and biomaterials with immunologic sensitization after mechanical support. J Thorac Cardiovasc Surg (2008) 1.16
Posttransplant survival is not diminished in heart transplant recipients bridged with implantable left ventricular assist devices. J Thorac Cardiovasc Surg (2009) 1.14
Percutaneous transcatheter aortic valve closure successfully treats left ventricular assist device-associated aortic insufficiency and improves cardiac hemodynamics. JACC Cardiovasc Interv (2013) 1.12
A minimally invasive approach is more cost-effective than a traditional sternotomy approach for mitral valve surgery. J Thorac Cardiovasc Surg (2011) 1.11
Hull down on the horizon: A Randomized trial of Unruptured Brain Arteriovenous malformations (ARUBA) trial. Stroke (2012) 1.11
Who is the high-risk recipient? Predicting mortality after heart transplant using pretransplant donor and recipient risk factors. Ann Thorac Surg (2011) 1.09
Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: a report from the Cardiothoracic Surgical Trials Network. J Thorac Cardiovasc Surg (2011) 1.08
The combined organ effect: protection against rejection? Ann Surg (2008) 1.07
Effect of left ventricular assist device infection on post-transplant outcomes. J Heart Lung Transplant (2009) 1.05
Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response. Hepatology (2014) 1.05
A statewide experience with endovascular abdominal aortic aneurysm repair: rapid diffusion with excellent early results. J Vasc Surg (2004) 1.04
Prospective, multicenter study of ventricular assist device infections. Circulation (2013) 1.03
Comparative effectiveness of minimally invasive versus traditional sternotomy mitral valve surgery in elderly patients. J Thorac Cardiovasc Surg (2012) 1.03
Matching high-risk recipients with marginal donor hearts is a clinically effective strategy. Ann Thorac Surg (2009) 1.02
The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg (2007) 1.00
Post-heart transplant survival is inferior at low-volume centers across all risk strata. Circulation (2010) 0.99
Infection after implantation of pulsatile mechanical circulatory support devices. J Thorac Cardiovasc Surg (2010) 0.94
Designing comparative effectiveness trials of surgical ablation for atrial fibrillation: experience of the Cardiothoracic Surgical Trials Network. J Thorac Cardiovasc Surg (2011) 0.92
Weighting composite endpoints in clinical trials: essential evidence for the heart team. Ann Thorac Surg (2012) 0.90
Propensity score-matched analysis of open surgical and endovascular repair for type B aortic dissection. Int J Vasc Med (2011) 0.90
Comparisons of infection complications between continuous flow and pulsatile flow left ventricular assist devices. J Thorac Cardiovasc Surg (2007) 0.89
Payer status and treatment paradigm for acute cholecystitis. Arch Surg (2012) 0.89
The use of mechanical circulatory support as a bridge to transplantation in pediatric patients: an analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg (2008) 0.89
Promising practices: how leading safety-net plans are managing the care of Medicaid clients. Health Aff (Millwood) (2002) 0.88
Effect of epicardial fat on ablation performance: a three-energy source comparison. J Card Surg (2007) 0.88
Standard versus bicaval techniques for orthotopic heart transplantation: an analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg (2010) 0.87
Randomized trials in surgery. Surgery (2009) 0.87
Discharge to home rates are significantly lower for octogenarians undergoing coronary artery bypass graft surgery. Ann Thorac Surg (2007) 0.87
Predicting survival among high-risk pediatric cardiac transplant recipients: an analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg (2007) 0.86
A consideration of user financial incentives to address health inequalities. J Health Polit Policy Law (2011) 0.85
Radiofrequency and microwave energy sources in surgical ablation of atrial fibrillation: a comparative analysis. Heart Surg Forum (2006) 0.85
Development of a novel scoring tool for the identification of large ≥5 cm abdominal aortic aneurysms. Ann Surg (2010) 0.85
Adjunctive renal sympathetic denervation to modify hypertension as upstream therapy in the treatment of atrial fibrillation (H-FIB) study: clinical background and study design. J Cardiovasc Electrophysiol (2013) 0.85